martes, 10 de junio de 2014

American Gastroenterological Association In... [Gastroenterology. 2013] - PubMed - NCBI

American Gastroenterological Association In... [Gastroenterology. 2013] - PubMed - NCBI



 2013 Dec;145(6):1459-63. doi: 10.1053/j.gastro.2013.10.047.

American Gastroenterological Association Institute guideline on the use of thiopurines, methotrexate, and anti-TNF-α biologic drugs for the induction and maintenance of remission in inflammatory Crohn's disease.

KEYWORDS:

AGA; American Gastroenterological Association Institute; CD; Crohn's disease; Development and Evaluation; GRADE; Grading of Recommendations Assessment; PICO; TNF; and outcome; comparator; intervention; population; tumor necrosis factor

PMID:
 
24267474
 
[PubMed - indexed for MEDLINE]


full-text ►

American Gastroenterological Association Institute
National Guideline Clearinghouse (NGC)
Guideline Title
American Gastroenterological Association Institute guideline on the use of thiopurines, methotrexate, and anti–TNF-α biologic drugs for the induction and maintenance of remission in inflammatory Crohn's disease.
Bibliographic Source(s)
Terdiman JP, Gruss CB, Heidelbaugh JJ, Sultan S, Falck-Ytter YT, AGA Institute Clinical Practice and Quality Management Committee. American Gastroenterological Association Institute guideline on the use of thiopurines, methotrexate, and anti-TNF-a biologic drugs for the induction and maintenance of remission in inflammatory Crohn's disease. Gastroenterology. 2013 Dec;145(6):1459-63. [2 references] PubMed External Web Site Policy
Guideline Status
This is the current release of the guideline.

No hay comentarios: